The “Every Vape” Campaign Has a Blind Spot It Cannot Acknowledge

Australia’s public health establishment has become remarkably skilled at producing stakeholder toolkits. Every few months, a new campaign appears accompanied by carefully designed graphics, social media assets, talking points, educational materials, community engagement resources and messaging guides that are distributed throughout schools, health services, local councils and advocacy organisations. The branding changes, the slogans evolve and the imagery is refreshed, but the underlying message remains strikingly familiar. Vaping is presented primarily as a threat, a problem to be solved, a behaviour to be discouraged and ultimately something that should disappear.

The latest “Every Vape” stakeholder toolkit follows this increasingly familiar pattern. It provides supporters with resources designed to reinforce warnings about vaping, amplify concerns about nicotine addiction and encourage conversations that steer people towards quitting. At first glance, this may seem entirely reasonable. Public health campaigns have always sought to reduce behaviours perceived to carry health risks. The problem is not that the campaign discusses risks. The problem is what it leaves out.

The central question that should sit at the heart of any discussion about vaping is surprisingly absent from much of Australia’s public health messaging. Compared to what?

This question matters because vaping does not exist in a vacuum. The overwhelming majority of adult vapers are not individuals who would otherwise be living entirely nicotine-free lives. They are current smokers, former smokers or people who would likely have continued smoking had vaping not become available. Yet many contemporary campaigns avoid this comparison altogether and instead present vaping as though it exists independently of the smoking epidemic that gave rise to its popularity.

This omission fundamentally changes the nature of the discussion. When vaping is examined in isolation, it is easy to focus exclusively on its risks, uncertainties and potential harms. When vaping is compared to smoking, however, the conversation becomes more complex because smoking remains one of the most lethal consumer behaviours in human history. Cigarettes kill millions of people globally every year through diseases directly linked to the inhalation of smoke created by combustion. The question, therefore, is not whether vaping is completely harmless. Almost no serious advocate argues that it is. The question is whether smokers who switch to vaping are likely to reduce their exposure to the toxic chemicals produced by burning tobacco and whether this reduction could translate into meaningful health benefits.

Campaigns such as “Every Vape” often appear uncomfortable with this comparison because acknowledging relative risk immediately complicates a simple narrative. Once people begin comparing vaping to smoking, the conversation can no longer be reduced to slogans. It requires nuance. It requires a discussion of harm reduction. It requires acknowledging that not all nicotine products are equally dangerous. Most importantly, it requires accepting that public health policy sometimes involves choosing between imperfect options rather than pursuing an idealised vision of complete abstinence.

The language of the campaign reflects a deeper philosophical shift that has quietly occurred within parts of tobacco control. Historically, the central objective was reducing disease and death caused by smoking. This goal attracted widespread support because it was practical, evidence-based and focused on the most harmful form of nicotine consumption. Increasingly, however, the focus appears to have expanded beyond smoking and towards nicotine itself. The distinction is important because once nicotine becomes the primary enemy rather than combustible tobacco, products that dramatically differ in risk begin to be grouped under the same moral and political framework.

This helps explain why many campaigns now speak about vaping in ways that sound remarkably similar to the language once reserved for cigarettes. Differences become blurred. Distinctions become inconvenient. Relative risk disappears from public discussion. What remains is a simplified message designed to discourage all use rather than inform people about varying levels of risk.

The consequences of this approach are becoming increasingly difficult to ignore. Australia has spent years implementing some of the world’s most restrictive vaping policies while simultaneously claiming these measures would protect public health. Yet the outcomes visible across the country tell a more complicated story. Illicit vape markets have flourished. Organised criminal groups have entered nicotine supply chains. Retailers have become targets of intimidation, extortion and violence. Communities have witnessed a wave of tobacco-related crime that would have seemed unimaginable only a few years ago.

These developments were not random accidents. They were predictable responses to policy settings that attempted to suppress legal access while leaving demand largely unchanged. History repeatedly demonstrates that prohibition does not eliminate demand. It changes who supplies it. Whether the product is alcohol, illicit drugs, gambling or nicotine, severe restrictions often create opportunities for unregulated markets to expand. Australia is now confronting precisely these consequences.

What makes campaigns such as “Every Vape” particularly frustrating is their tendency to treat these outcomes as peripheral issues rather than central policy failures. The discussion remains focused on consumer behaviour while avoiding difficult questions about the effectiveness of the regulatory framework itself. More messaging is proposed. More education is recommended. More awareness campaigns are being developed. More stakeholders are recruited to amplify official narratives. Yet very little attention is devoted to asking whether the underlying strategy is achieving its intended objectives.

This reluctance to engage in self-reflection is becoming increasingly noticeable. Public health institutions frequently demand that consumers critically examine their behaviour, but they appear far less willing to critically examine their own assumptions. When outcomes fail to match expectations, the response is often to intensify the campaign rather than reassess the strategy.

Perhaps the greatest challenge facing campaigns like “Every Vape” is the growing disconnect between official messaging and lived experience. Across Australia millions of people know friends, family members or colleagues who have successfully quit smoking using vaping products. They have witnessed smokers who struggled for years with nicotine replacement therapies, counselling programs, and repeated quit attempts eventually transition away from cigarettes through vaping. These experiences are real, visible and impossible to dismiss simply because they complicate a preferred narrative.

When public health campaigns fail to acknowledge these experiences, they create a credibility problem. People naturally compare official claims with what they observe around them. If the gap between messaging and experience becomes too large, trust begins to erode. Consumers become sceptical. They start looking for information elsewhere. They question whether important facts are being omitted. They become less willing to accept official guidance at face value.

Trust is one of the most valuable assets any public health institution possesses. It cannot be maintained through repetition alone. It requires transparency, honesty and a willingness to acknowledge complexity. When campaigns appear to selectively present evidence or avoid discussing inconvenient realities, they risk undermining the very trust they seek to build.

The phrase “Every Vape” itself illustrates this problem. It suggests a uniformity that does not exist. Every vape is not the same. Every person who vapes is not the same. Every circumstance is not the same. A teenager experimenting with nicotine for the first time presents a different public health challenge from a sixty-year-old smoker who has switched after decades of tobacco use. Treating these situations as though they are interchangeable may simplify campaign messaging, but it does little to improve public understanding.

Public health should be capable of handling complexity. It should be capable of acknowledging that products can carry risks while still offering benefits relative to more dangerous alternatives. It should be capable of discussing uncertainty without resorting to absolutism. Most importantly, it should be capable of trusting the public with nuanced information rather than reducing every debate to a choice between endorsement and condemnation.

The deeper issue exposed by campaigns such as “Every Vape” is not vaping itself. It is the growing tendency of institutions to substitute messaging for inquiry. The purpose of a stakeholder toolkit is not to investigate difficult questions. It is to align stakeholders around predetermined answers. It is designed to build consensus, not encourage debate. It is intended to reinforce an existing narrative rather than challenge it.

That approach may be effective in generating short-term agreement among organisations already committed to a particular position, but it is far less effective at persuading the public that increasingly demands transparency and evidence. Australians are not merely passive recipients of health messaging. They observe outcomes. They compare claims with reality. They notice contradictions. They recognise when important parts of a story are missing.

This is why the future of public health communication may depend less on producing more campaigns and more on rebuilding credibility. The challenge is no longer a lack of awareness. Australians are already surrounded by warnings, advertisements, educational materials and public health messaging. The challenge is creating communications that people trust.

Trust cannot be manufactured through slogans. It cannot be achieved through repetition. It cannot be sustained by ignoring evidence that complicates official narratives. It emerges when institutions demonstrate intellectual honesty, acknowledge uncertainty and engage seriously with competing perspectives.

One of the clearest examples of the problems with the “Every Vape” campaign can be found in its own promotional material. A recent post from Quit claims that because legal and illegal vapes contain a range of chemicals, “it’s clear that every vape is a hit to your health.” Accompanying graphics ask “What’s in a vape?” and list nicotine, formaldehyde, flavour compounds, acetaldehyde and acrolein as evidence that vaping is inherently dangerous.

At first glance, this appears alarming. The average reader is presented with a list of unfamiliar chemical names and is encouraged to conclude that vaping must therefore be highly hazardous. Yet this style of communication has long been criticised because it relies on the presence of chemicals rather than their quantity, context or comparative risk.

Everything around us is made of chemicals. The relevant question is not whether a substance can be detected, but how much is present and whether the exposure is significant enough to cause harm. Public health campaigns know this. Toxicology has always been based on dose, exposure and risk, not simply the existence of a chemical.

The inclusion of formaldehyde is particularly revealing. Formaldehyde is often highlighted because it sounds frightening and because it is classified as a carcinogen. What is rarely explained is that formaldehyde is also naturally present in the human body, produced during normal metabolic processes and found in many everyday foods. More importantly, smokers are exposed to dramatically higher levels of formaldehyde through cigarette smoke than vapers are through properly functioning vaping products. By mentioning formaldehyde without this comparison, the campaign encourages fear while withholding the information necessary to understand relative risk.

The same pattern applies to acetaldehyde and acrolein. These compounds can be detected in vape aerosol, but they are also present at far higher levels in cigarette smoke. If the purpose of public health is to help smokers move away from the most dangerous products, then omitting this comparison is not a trivial oversight. It removes the very context that makes the information meaningful.

Even the inclusion of nicotine is revealing. Nicotine is addictive and should not be used by children or non-smokers. However, nicotine itself is not the primary cause of smoking-related cancers, cardiovascular disease and respiratory illness. The overwhelming burden of smoking-related death comes from inhaling the thousands of toxic products created by combustion. By placing nicotine alongside carcinogens and toxic chemicals, campaigns often blur the distinction between addiction and disease, encouraging the public to believe that nicotine itself is responsible for the harms primarily caused by smoke.

Perhaps the most striking feature of the advertisement is its decision to place legal and illegal products into the same category. Legal therapeutic vaping products manufactured under quality standards are fundamentally different from illicit products produced through unregulated supply chains. Yet the campaign merges them and then uses the risks associated with illicit products to support broad claims about vaping in general.

This creates a convenient rhetorical strategy. Every adverse finding from illegal products becomes evidence against legal products. Every contamination issue discovered in the black market becomes evidence against regulated products. The distinction disappears, even though public health advocates routinely argue in other contexts that regulation improves safety.

The campaign, therefore, illustrates a broader problem within Australia’s vaping debate. Information is often presented in a way that maximises concern while minimising context. Chemicals are listed without reference to dose. Risks are described without comparison to smoking. Illegal and legal products are merged. Nicotine is treated as though it were synonymous with smoking-related disease. The result is not a balanced public health message but a carefully constructed narrative designed to support a predetermined conclusion.

For many Australians, particularly former smokers who successfully switched to vaping, this style of communication no longer feels educational. It feels promotional. Rather than increasing trust, it reinforces the perception that public health organisations are more interested in discouraging vaping at all costs than in providing a complete and honest account of the evidence.

That may explain why campaigns such as “Every Vape” increasingly struggle to persuade the very audiences they are trying to reach. People can recognise when important context has been omitted. They understand the difference between information and advocacy. And the more often public health campaigns rely on fear, simplification and selective comparisons, the more difficult it becomes for those institutions to maintain their credibility.

Until that happens, campaigns like “Every Vape” will continue to persuade those who already agree while leaving many others unconvinced. The more aggressively they attempt to simplify a complex issue, the more obvious their omissions become. And the more obvious those omissions become, the harder it will be for public health institutions to maintain the credibility upon which their influence ultimately depends.